Serum kynurenine/tryptophan ratio is not a potential marker for detecting prostate cancer

Clin Biochem. 2014 Sep;47(13-14):1347-8. doi: 10.1016/j.clinbiochem.2014.05.001. Epub 2014 May 13.

Authors

Giovanny Rodríguez-Blanco¹, Peter C Burgers¹, Lennard J M Dekker¹, Mirella S Vredenbregt-van den Berg², Jan N M Ijzermans³, Ellen A M Schenk-Braat², Guido Jenster², Theo M Luider⁴

Affiliations

¹ Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands.
² Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands.
³ Department of Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands.
⁴ Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands. Electronic address: t.luider@erasmusmc.nl.

PMID: 24833358
DOI: 10.1016/j.clinbiochem.2014.05.001

No abstract available

Keywords: Biomarker; IDO; Kynurenine; Prostate cancer; Tryptophan.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Biomarkers / blood*
Case-Control Studies
Humans
Kynurenine / blood*
Male
Middle Aged
Prostatic Neoplasms / blood*
Prostatic Neoplasms / diagnosis*
Tryptophan / blood*

Substances

Biomarkers
Kynurenine
Tryptophan